The Food and Drug Administration (FDA) has introduced new guidelines for COVID-19 vaccines, focusing on those at highest risk for severe complications. The updated strategy will maintain the ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

Top officials for the Food and Drug Administration laid out new requirements ... updates to COVID-19 vaccines, similar to the annual flu shot. As with flu vaccines, until now the FDA has approved ...

Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new ... set to debate which vaccines should be recommended to which groups. The FDA ...

Photo: Win McNamee/Getty The Trump administration released a more stringent set of guidelines for approving Covid ... FDA Commissioner Dr. Marty Makary and the agency’s new vaccines chief ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to ...

Top officials for the Food and Drug Administration laid out new requirements ... to COVID-19 vaccines, similar to the annual flu shot. Just like with flu vaccines, until now the FDA has approved ...

Top officials for the Food and Drug Administration laid out new standards for updated COVID ... the CDC is set to debate which vaccines should be recommended to which groups. The FDA's ...